Home » Newsletters » BioWorld Science

BioWorld Science

March 21, 2022

View Archived Issues

Immune suppressive glycoprotein-targeting MAb reported

CAP2 is increased in patients with AD and correlates with tau pathology

PP2B inhibition clears tau toxicity in experimental AD

Amyloid beta 42 impacts the expression of SPPL2B in AD

Anc80L65 vector combined with new surgical technique for hearing loss gene therapy

OLX-07010 shows promising efficacy in mouse models of tauopathy

TREM2 agonistic MAb attenuates tau burden and neurodegeneration

Researchers develop new murine model of AD

Sorrento reports findings with universal chimeric mRNA based COVID-19 vaccine

ALS Therapy Development Institute patents new compounds for ALS

Merck & Co. synthesizes new anti-HIV compounds

MagicMed Industries presents 5-HT2A receptor agonists

Incyte divulges new JAK2 inhibitors

Vertex Pharmaceuticals synthesizes new APOL1 inhibitors

Volastra collaborates with Bristol Myers Squibb to discover and develop oncology drug candidates

Grant supports Neuromagen's development of AGS-499 for ALS

Ixaka expands IP portfolio to allow use of TNP gene delivery platform across multiple areas

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.